Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108


A research agenda for enhancing appropriate opioid prescribing in primary care.

Becker WC, Fraenkel L, Kerns RD, Fiellin DA.

J Gen Intern Med. 2013 Oct;28(10):1364-7. doi: 10.1007/s11606-013-2422-4. Epub 2013 Apr 9. Review.


Long-term opioid therapy reconsidered.

Von Korff M, Kolodny A, Deyo RA, Chou R.

Ann Intern Med. 2011 Sep 6;155(5):325-8. doi: 10.7326/0003-4819-155-5-201109060-00011.


Combating the increase in opioid misuse.

Nolan W, Gannon R.

Conn Med. 2013 Sep;77(8):495-8. No abstract available.


Preventing prescription opioid overdose deaths.

Rastegar DA, Walley AY.

J Gen Intern Med. 2013 Oct;28(10):1258-9. doi: 10.1007/s11606-013-2390-8. No abstract available.


Group Health's initiative to avert opioid misuse and overdose among patients with chronic noncancer pain.

Trescott CE, Beck RM, Seelig MD, Von Korff MR.

Health Aff (Millwood). 2011 Aug;30(8):1420-4. doi: 10.1377/hlthaff.2011.0759.


Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain.

Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ.

Ann Intern Med. 2010 Jun 1;152(11):712-20. doi: 10.7326/0003-4819-152-11-201006010-00004. Review.


Potential misuse and inappropriate prescription practices involving opioid analgesics.

Liu Y, Logan JE, Paulozzi LJ, Zhang K, Jones CM.

Am J Manag Care. 2013 Aug;19(8):648-65.


Opioid use in primary care: asking the right questions.

Lewis ET, Trafton JA.

Curr Pain Headache Rep. 2011 Apr;15(2):137-43. doi: 10.1007/s11916-010-0172-0. Review.


Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations.

Kahan M, Wilson L, Mailis-Gagnon A, Srivastava A; National Opioid Use Guideline Group.

Can Fam Physician. 2011 Nov;57(11):1269-76, e419-28. English, French.


Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).

Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P.

Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23.


Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges.

Bruehl S, Apkarian AV, Ballantyne JC, Berger A, Borsook D, Chen WG, Farrar JT, Haythornthwaite JA, Horn SD, Iadarola MJ, Inturrisi CE, Lao L, Mackey S, Mao J, Sawczuk A, Uhl GR, Witter J, Woolf CJ, Zubieta JK, Lin Y.

J Pain. 2013 Feb;14(2):103-13. doi: 10.1016/j.jpain.2012.10.016. Review.


Clinical strategies for the primary health care professional to minimize prescription opioid abuse.

Gudin JA.

Postgrad Med. 2012 May;124(3):131-8. doi: 10.3810/pgm.2012.05.2556. Review.


American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.

Manchikanti L, Abdi S, Atluri S, Balog CC, Benyamin RM, Boswell MV, Brown KR, Bruel BM, Bryce DA, Burks PA, Burton AW, Calodney AK, Caraway DL, Cash KA, Christo PJ, Damron KS, Datta S, Deer TR, Diwan S, Eriator I, Falco FJ, Fellows B, Geffert S, Gharibo CG, Glaser SE, Grider JS, Hameed H, Hameed M, Hansen H, Harned ME, Hayek SM, Helm S 2nd, Hirsch JA, Janata JW, Kaye AD, Kaye AM, Kloth DS, Koyyalagunta D, Lee M, Malla Y, Manchikanti KN, McManus CD, Pampati V, Parr AT, Pasupuleti R, Patel VB, Sehgal N, Silverman SM, Singh V, Smith HS, Snook LT, Solanki DR, Tracy DH, Vallejo R, Wargo BW; American Society of Interventional Pain Physicians.

Pain Physician. 2012 Jul;15(3 Suppl):S67-116.


Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2011 Nov 4;60(43):1487-92.


Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.

Gudin JA, Mogali S, Jones JD, Comer SD.

Postgrad Med. 2013 Jul;125(4):115-30. doi: 10.3810/pgm.2013.07.2684. Review.


Opioid prescribing: can the art become more science?

Alford DP.

J Gen Intern Med. 2013 Oct;28(10):1253-4. doi: 10.1007/s11606-013-2493-2. No abstract available.


Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting.

Brown J, Setnik B, Lee K, Wase L, Roland CL, Cleveland JM, Siegel S, Katz N.

J Opioid Manag. 2011 Nov-Dec;7(6):467-83.


Misuse of and dependence on opioids: study of chronic pain patients.

Kahan M, Srivastava A, Wilson L, Gourlay D, Midmer D.

Can Fam Physician. 2006 Sep;52(9):1081-7. Review.


Patient satisfaction, prescription drug abuse, and potential unintended consequences.

Zgierska A, Miller M, Rabago D.

JAMA. 2012 Apr 4;307(13):1377-8. doi: 10.1001/jama.2012.419. No abstract available.


Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain.

Chou R, Fanciullo GJ, Fine PG, Adler JA, Ballantyne JC, Davies P, Donovan MI, Fishbain DA, Foley KM, Fudin J, Gilson AM, Kelter A, Mauskop A, O'Connor PG, Passik SD, Pasternak GW, Portenoy RK, Rich BA, Roberts RG, Todd KH, Miaskowski C; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel.

J Pain. 2009 Feb;10(2):113-30. doi: 10.1016/j.jpain.2008.10.008.

Items per page

Supplemental Content

Write to the Help Desk